Skip to content
2000
Volume 14, Issue 2
  • ISSN: 1871-5206
  • E-ISSN: 1875-5992

Abstract

Traditional anti-cancer therapies (surgery, radiotherapy and chemotherapy) have limited effectiveness in curbing progression of advanced tumors. However, with advances in immunology and molecular biology in the last two decades, the prognosis of cancer immunotherapy has improved. An emerging therapy is the cancer vaccine as adjunctive therapy. The purpose of this paper is to review this therapeutic modality for non-small cell lung cancer.

Loading

Article metrics loading...

/content/journals/acamc/10.2174/18715206113136660378
2014-02-01
2025-04-22
Loading full text...

Full text loading...

/content/journals/acamc/10.2174/18715206113136660378
Loading

  • Article Type:
    Research Article
Keyword(s): Immunotherapy; MAGE-A3; MUC1; non-small cell lung cancer; tumor antigens; vaccine
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test